Pc. Gerszten et al., INTRACRANIAL EPENDYMOMAS OF CHILDHOOD - LACK OF CORRELATION OF HISTOPATHOLOGY AND CLINICAL OUTCOME, Pathology research and practice, 192(6), 1996, pp. 515-522
The histopathology of 66 children with the diagnosis of ependymoma who
were operated on at our institution between 1954 and 1994 were review
ed. We performed an initial analysis using the entire study cohort to
determine which histopathological features associated with each other
in a statistically significant fashion in an attempt to identify combi
nations of features that together might be useful in predicting outcom
e. A detailed outcome analysis was then performed on the 37 most recen
t cases who survived the postoperative period in whom pre- and post-im
aging studies as well as long term follow-up were obtained, in order t
o identify the histopathological features and combinations of features
that were predictive of overall and progression-free survival. Five-
and ten-year progression-free survivals were 45.1% and 36.1%, respecti
vely. Overall survivals were 57.1% and 45.0%, respectively. Of the eig
ht individual histopathological features, only the presence of necrosi
s was found to correlate with a less favorable overall and progression
-free survival (PFS) (p = 0.06 and 0.03, respectively). In addition, t
he combination of necrosis with vascular proliferation or nuclear pleo
morphism was associated with a worse PFS (p = 0.01 and 0.02, respectiv
ely). However, when other clinical predictive factors were included in
a multivariate regression analysis, none of the histological features
or combinations of features were independently associated with outcom
e. In addition, no relationship was found between the pattern of roset
tes (true rosette, pseudorosette, or perivascular pseudorosette) and c
linical outcome. In conclusion, although this study found an associati
on between certain histopathological features and clinical outcome in
children with ependymomas, these relationships did not reach statistic
al significance on multivariate analysis and, thus, do not provide suf
ficient evidence for modifying therapy based on histopathology alone.